Sequential electrophilic P-C bond formation in metal-coordinated chlorophosphines

Substituted aromatic pentaphosphole ligands - a journey across the p-block

The functionalization of pentaphosphaferrocene [Cp*Fe(η5-P5)] (1) with cationic group 13-17 electrophiles is shown to be a general synthetic strategy towards P-E bond formation of unprecedented diversity. The products of these reactions are dinuclear [{Cp*Fe}2{μ,η5:5-(P5)2EX2}][TEF] (EX2 = BBr2 (2), GaI2 (3), [TEF]- = [Al{OC(CF3)3}4]-) or mononuclear [Cp*Fe(η5-P5E)][X] (E = CH2Ph (4), CHPh2 (5), SiHPh2 (6), AsCy2 (7), SePh (9), TeMes (10), Cl (11), Br (12), I (13)) complexes of hetero-bis-pentaphosphole ((cyclo-P5)2R) or hetero-pentaphosphole ligands (cyclo-P5R), the aromatic all-phosphorus analogs of prototypical cyclopentadienes. Further, modifying the steric and electronic properties of the electrophile has a drastic impact on its reactivity and leads to the formation of [Cp*Fe(μ,η5:2-P5)SbICp'''][TEF] (8) which possesses a triple-decker-like structure. X-ray crystallographic characterization reveals the slightly twisted conformation of the cyclo-P5R ligands in these compounds and multinuclear NMR spectroscopy confirms their integrity in solution. DFT calculations shed light on the bonding situation of these compounds and confirm the aromatic character of the pentaphosphole ligands on a journey across the p-block.

Unconventional ionic ring-deconstruction pathways of a three-membered heterocycle

Two different ionic deconstruction reactions of the oxaphosphirane ring in I are reported. One is induced by base and involves displacement of the aldehyde unit forming II whilst acid-initiated extrusion of the ring-carbon with its substituents yielded III. Further insights into the latter ring-deconstruction were obtained by quantum chemical calculations.

Sequential Electrophilic Substitution Reactions of Tungsten-Coordinated Phosphenium Ions and Phosphine Triflates

ion of chloride from [W(CO)₅{PPhCl₂}] with AgOSO₂CF₃ leads to the phosphine triflate complex [W(CO)₅{PPhCl(OSO₂CF₃)}] which undergoes electrophilic substitution reactions with N,N-diethylaniline, anisole, N,N-dimethyl-p-toluidine, toluene, biphenyl, naphthalene, 2,7,9,9-tetramethyl xanthene, and allyltrimethylsilane to form the chlorophosphine complexes [W(CO)₅{PPhClR}], where R = p-diethylanilinyl, p-anisyl, 2-(N,N-dimethyl-4-methylphenyl), p-tolyl, p-phenylphenyl, 1-naphthyl, 4-(2,7,9,9-tetramethylxanthyl), and allyl. Abstraction of the second chloride with AgOSO₂CF₃ leads, in most cases, to the respective phosphine triflates [W(CO)₅{PPhR(OSO₂CF₃)}], which react with ferrocene to form the ferrocenyl phosphine complexes [W(CO)₅{PPhR(C₁₀H₉Fe)}]. The W(CO)₅ unit can be removed via photolysis in the presence of bis(diphenylphosphino)ethane to form metal-free phosphines.

A potent synthetic inorganic antibiotic with activity against drug-resistant pathogens

The acronymously named “ESKAPE” pathogens represent a group of bacteria that continue to pose a serious threat to human health, not only due to their propensity for repeated emergence, but also due to their ability to “eskape” antibiotic treatment12. The evolution of multi-drug resistance in these pathogens alone has greatly outpaced the development of new therapeutics, necessitating an alternative strategy for antibiotic development that considers the evolutionary mechanisms driving antibiotic resistance. In this study, we synthesize a novel inorganic antibiotic, phosphopyricin, which has antibiotic activity against the Gram-positive methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecium (VRE). We show that this potent antibiotic is bactericidal, and exhibits low toxicity in an acute dose assay in mice. As a synthetic compound that does not occur naturally, phosphopyricin would be evolutionarily foreign to microbes, thereby slowing the evolution of resistance. In addition, it loses antibiotic activity upon exposure to light, meaning that the active antibiotic will not accumulate in the general environment where strong selective pressures imposed by antibiotic residuals are known to accelerate resistance. Phosphopyricin represents an innovation in antimicrobials, having a synthetic core, and a photosensitive chemical architecture that would reduce accumulation in the environment.